New drug administration system to speed delivery time

Wednesday, Dec 16, 2009 @ 2:58pm by Nick Rees

SRI International has received a patent for a bioadhesive drug delivery system that uses the human body's mucous membranes to enable enhanced release of drugs through a needle-free option.
Read More »

XOMA Ltd., announces advances in neutralizing botulinum neurotoxin Type A

Friday, Dec 11, 2009 @ 4:36pm by Nick Rees

XOMA Ltd. has announced results that demonstrate its monoclonal antibody technology XOMA 3AB's ability to neutralize botulinum neurotoxin Type A, a bioterror threat that causes paralysis.
Read More »

Safety and simulation training begins at under-fire Boston University biosafety lab

Thursday, Dec 10, 2009 @ 2:36pm by BioPrepWatch Reports

Safety and simulation training has begun on Boston University's Biosafety Level-4 laboratory even as the National Institutes of Health continues weighing the labs safety options.
Read More »

UIC given funds to develop new bioweapon antibiotics

Friday, Dec 4, 2009 @ 3:30pm by Nick Rees

Four million dollars in stimulus package funds will be given to researchers at the University of Illinois at Chicago to aid in the development of new antibiotics to treat anthrax, tularemia and plague.
Read More »

Anthrax vaccine project stopped over animal rights

Monday, Nov 30, 2009 @ 3:03pm by Nick Rees

Oklahoma State University has put a stop to a project meant to test anthrax vaccines and treatment on baboons.
Read More »

Major smallpox vaccine order announcement expected

Friday, Nov 27, 2009 @ 11:52pm by BioPrepWatch Reports

The biodefense company SIGA Technologies, which engages in the discovery, development and commercialization of products for use in defense against biological warfare agents, is expected to make a major announcement.
Read More »

Consortium formed to create thermostable ricin vaccine

Monday, Nov 23, 2009 @ 3:24pm by Nick Rees

Soligenix, Inc., a late-stage biotechnology company, has announced that is has formed a consortium to aid in developing thermostable technology to advance RiVax and other rapidly acting vaccines.
Read More »

Grant goes to Purdue University to fund research into life cycle of potential bioweapon viruses

Thursday, Nov 19, 2009 @ 4:03pm by Nick Rees

The life cycles of two virus types that could be used as biological weapons will be researched with funding from a National Institutes of Health agency with the hope of creating better treatments against them.
Read More »

Kent State University becomes 2nd in U.S. to offer biosafety training

Saturday, Nov 14, 2009 @ 4:41pm by BioPrepWatch Reports

KENT, Ohio
Read More »

University of Illinois to develop antibiotics against potential bioterrorism agents

Friday, Nov 13, 2009 @ 5:03pm by BioPrepWatch Reports

Researchers at the University of Illinois at Chicago have received a $4 million federal grant to develop new antibiotics to treat anthrax, tularemia and plague, the university announced Nov. 10.
Read More »

Scientists Announce Possible Treatment for Deadly Virus

Thursday, Nov 12, 2009 @ 5:10pm by BioPrepWatch Reports

A team of Australian and U.S. scientists believe they have found an antibody that could protect humans from the deadly Hendra virus, Australia's Northern Miner reported yesterday.
Read More »

NIH awards grant to Biolog to aid biodefense researchers

Wednesday, Nov 11, 2009 @ 9:54pm by BioPrepWatch Reports

The National Institutes of Health recently awarded Biolog Inc. $923,000 to help it develop a next-generation version of the firm's cell array technology.
Read More »

NIAID awards Northrop Grumman for bioinformatics resource centers

Saturday, Nov 7, 2009 @ 8:04pm by BioPrepWatch Reports

Read More »

NIAID announces research awards to fight emerging infectious diseases

Friday, Nov 6, 2009 @ 2:17am by BioPrepWatch Reports

The National Institute of Allergy and Infectious Diseases has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases.
Read More »

Albany Medical College to fund biodefense research of tularemia

Tuesday, Oct 20, 2009 @ 3:39pm by BioPrepWatch Reports

Read More »

DOR BioPharma awarded $500,000 for clinical study

Monday, Sep 14, 2009 @ 10:43pm by BioPrepWatch Reports

PRINCETON, N.J. -- The NIH has awarded DOR BioPharma a $500,000 Small Business Innovation Research grant to support a clinical evlauat
Read More »